CLINICAL_TRIALS
trial_result
· 2025-03-19
Clinical Trial Update: A Study of JR-171 in Patients With Mucopolysaccharidosis I [Phase 1, Phase 2]
Summary
JR-171, investigated for Mucopolysaccharidosis I, completed a Phase 1/2 trial and posted results on 2025-03-19.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis I | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-19